EBR.AX - EBR Systems, Inc.
ASX - ASX Delayed price. Currency in AUD
As of 10:08AM AEST. Market open.
Stock chart is not supported by your current browser
| Previous close | 1.1250 |
| Open | 1.1250 |
| Bid | 1.1250 x N/A |
| Ask | 1.1400 x N/A |
| Day's range | 1.1250 - 1.1250 |
| 52-week range | 0.3300 - 1.3500 |
| Volume | |
| Avg. volume | 247,987 |
| Market cap | 304.694M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1800 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.16 |
PR NewswireEBR Systems' Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results Lead to Early Trial Halt for Success
EBR Systems, Inc. (ASX: EBR), the medical device company developing wireless cardiac pacing systems, has met its primary safety and efficacy endpoints in its pivotal SOLVE-CRT trial of the WiSE® Cardiac Resynchronization Therapy (CRT) System.
- PR Newswire
WiSE® Technology to Feature in Upcoming APHRS Scientific Session
EBR Systems, Inc. (ASX: "EBR", "EBR Systems", or the "Company"), developer of the world's only wireless cardiac pacing system for heart failure, is pleased to announce that the Company's WiSE® technology will be featured at the 15th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session in Singapore from the 18th to the 20th of November.